Pratumsuwan Piratip 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Pratumsuwan Piratip
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+51,181→ 51,181 totalExercise: $10.56Exp: 2035-02-03→ Common Stock (51,181 underlying) - Award
Stock Option (Right to Buy)
2025-02-03+22,443→ 22,443 totalExercise: $10.56Exp: 2035-02-03→ Common Stock (22,443 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 51,181 shares of Rocket Pharmaceutical, Inc. (the "Issuer")'s common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on February 3, 2028.
- [F2]This option represents a right to purchase a total of 22,443 shares of the Issuer's common stock, which will fully vest on February 3, 2026.